Basic and Clinical Research on Renal Cell Carcinoma
Seiten
1992
Springer Berlin (Hersteller)
978-3-540-54424-1 (ISBN)
Springer Berlin (Hersteller)
978-3-540-54424-1 (ISBN)
Lese- und Medienproben
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
An overview of clinical and research developments with advanced renal cell carcinoma, which contains a number of approaches designed to enhance the effectiveness of treatment. The preliminary results of current clinical trials with biological modifiers are also presented.
Advanced Renal Cell Carcinoma (RCC) cannot be cured by surgery alone. Its resillience to irradiation and chemotherapy demands a new approach to the management of this disease. This book provides an overview of the scientific and clinical developments of RCC, and clarifies the fields of immunotherapy and immunobiology. The book contains a compilation of approaches that will enhance the effectiveness of the management of advanced RCC, even in the absence of definitive pre-clinical data. These require additional study and will stimulate the reassessment of preliminary results. Furthermore, preliminary results of already implemented clinical trials with biological modifiers are presented. Of special interest are the current achievements in the field of immunotherapy using topically and subcutaneously low dosage combinations of cytokines.
Advanced Renal Cell Carcinoma (RCC) cannot be cured by surgery alone. Its resillience to irradiation and chemotherapy demands a new approach to the management of this disease. This book provides an overview of the scientific and clinical developments of RCC, and clarifies the fields of immunotherapy and immunobiology. The book contains a compilation of approaches that will enhance the effectiveness of the management of advanced RCC, even in the absence of definitive pre-clinical data. These require additional study and will stimulate the reassessment of preliminary results. Furthermore, preliminary results of already implemented clinical trials with biological modifiers are presented. Of special interest are the current achievements in the field of immunotherapy using topically and subcutaneously low dosage combinations of cytokines.
Zusatzinfo | 62 figs., 33 tabs. |
---|---|
Verlagsort | Berlin |
Sprache | englisch |
Gewicht | 542 g |
Einbandart | gebunden |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
Schlagworte | Nierenkrebs |
ISBN-10 | 3-540-54424-0 / 3540544240 |
ISBN-13 | 978-3-540-54424-1 / 9783540544241 |
Zustand | Neuware |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |